Publications:

ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma.

Canadian Journal Of Gastroenterology & Hepatology

Feng, Yuanyuan Y; Tang, Xinfang X; Li, Changcheng C; Su, Ying Y; Wang, Xiaoyu X; Li, Ning N; Zhang, Anna A; Jiang, Feng F; Wu, Chuyan C

Publication Date: 2022

Variant appearance in text: CD4: A22L

PubMed Link: 35028302

Variant Present in the following documents:

• CJGH2022-3163955.pdf

View BVdb publication page

High Expression Levels of SLC38A1 Are Correlated with Poor Prognosis and Defective Immune Infiltration in Hepatocellular Carcinoma.

Journal Of Oncology

Liu, Yun Y; Yang, Yong Y; Jiang, Linna L; Xu, Hongrui H; Wei, Junwei J

Publication Date: 2021

Variant appearance in text: CD4: A22L

PubMed Link: 34697542

Variant Present in the following documents:

• JO2021-5680968.pdf

View BVdb publication page

EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic Orthopoxviruses.

Journal Of Immunology Research

Molero-Abraham, Magdalena M; Glutting, John-Paul JP; Flower, Darren R DR; Lafuente, Esther M EM; Reche, Pedro A PA

Publication Date: 2015

Variant appearance in text: CD4: A22L

PubMed Link: 26605344

Variant Present in the following documents:

• JIR2015-738020.pdf

View BVdb publication page